Published in Cell Cycle on June 01, 2006
Granulosa cell-specific androgen receptors are critical regulators of ovarian development and function. Mol Endocrinol (2010) 1.57
The role of the aryl hydrocarbon receptor in the female reproductive system. Biochem Pharmacol (2008) 1.25
The mouse follicle microenvironment regulates antrum formation and steroid production: alterations in gene expression profiles. Biol Reprod (2008) 1.23
WNT4 is required for normal ovarian follicle development and female fertility. FASEB J (2010) 1.19
Micro-RNA378 (miR-378) regulates ovarian estradiol production by targeting aromatase. Endocrinology (2011) 1.19
Insulin and hyperandrogenism in women with polycystic ovary syndrome. J Steroid Biochem Mol Biol (2009) 1.14
Cross-talk between G protein-coupled and epidermal growth factor receptors regulates gonadotropin-mediated steroidogenesis in Leydig cells. J Biol Chem (2008) 1.07
Retracted The expression and ovarian steroid regulation of endometrial micro-RNAs. Reprod Sci (2008) 1.00
Transactivation of micrornA-320 by microRNA-383 regulates granulosa cell functions by targeting E2F1 and SF-1 proteins. J Biol Chem (2014) 0.96
Multiple roles for sphingolipids in steroid hormone biosynthesis. Subcell Biochem (2008) 0.91
Polycystic ovary syndrome, insulin resistance, and obesity: navigating the pathophysiologic labyrinth. Int J Reprod Med (2014) 0.90
Immunoreactivities of androgen receptor, estrogen receptors, p450arom, p450c17 proteins in wild ground squirrels ovaries during the nonbreeding and breeding seasons. J Ovarian Res (2012) 0.87
GPCR/EGFR cross talk is conserved in gonadal and adrenal steroidogenesis but is uniquely regulated by matrix metalloproteinases 2 and 9 in the ovary. Mol Endocrinol (2011) 0.87
The interplay between bioactive sphingolipids and steroid hormones. Steroids (2010) 0.81
Progressive obesity alters ovarian folliculogenesis with impacts on pro-inflammatory and steroidogenic signaling in female mice. Biol Reprod (2014) 0.79
Effects of steroid ablation and progestin replacement on the transcriptome of the primate corpus luteum during simulated early pregnancy. Mol Hum Reprod (2013) 0.78
Identification of androgen receptor phosphorylation in the primate ovary in vivo. Reproduction (2010) 0.77
Developmental programming: prenatal steroid excess disrupts key members of intraovarian steroidogenic pathway in sheep. Endocrinology (2014) 0.77
Steroidogenesis-related gene expression in the rat ovary exposed to melatonin supplementation. Clinics (Sao Paulo) (2015) 0.76
Prohibitin regulates the FSH signaling pathway in rat granulosa cell differentiation. J Mol Endocrinol (2016) 0.76
Regulation of mitogen-activated protein kinase 3/1 activity during meiosis resumption in mammals. J Reprod Dev (2015) 0.75
piRNA-associated proteins and retrotransposons are differentially expressed in murine testis and ovary of aryl hydrocarbon receptor deficient mice. Open Biol (2016) 0.75
Sex Change in Clownfish: Molecular Insights from Transcriptome Analysis. Sci Rep (2016) 0.75
Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev (1995) 7.16
Generation and reproductive phenotypes of mice lacking estrogen receptor beta. Proc Natl Acad Sci U S A (1998) 5.86
Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev (1997) 5.83
Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes (1989) 3.74
EGF-like growth factors as mediators of LH action in the ovulatory follicle. Science (2004) 3.66
Generation and characterization of androgen receptor knockout (ARKO) mice: an in vivo model for the study of androgen functions in selective tissues. Proc Natl Acad Sci U S A (2002) 3.08
Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N Engl J Med (1996) 2.77
The beta(2)-adrenergic receptor mediates extracellular signal-regulated kinase activation via assembly of a multi-receptor complex with the epidermal growth factor receptor. J Biol Chem (2000) 2.44
New mechanisms in heptahelical receptor signaling to mitogen activated protein kinase cascades. Oncogene (2001) 2.12
Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N Engl J Med (1998) 2.04
Progesterone-regulated genes in the ovulation process: ADAMTS-1 and cathepsin L proteases. Proc Natl Acad Sci U S A (2000) 1.98
Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone. J Clin Endocrinol Metab (2000) 1.87
Hormonal doping and androgenization of athletes: a secret program of the German Democratic Republic government. Clin Chem (1997) 1.74
Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus. J Clin Invest (1995) 1.70
Gonadotropic control of ovarian follicular growth and development. Mol Cell Endocrinol (2001) 1.68
Androgen excess is the key element in polycystic ovary syndrome. Fertil Steril (2003) 1.56
Ligand-independent activation of platelet-derived growth factor receptor is a necessary intermediate in lysophosphatidic, acid-stimulated mitogenic activity in L cells. Proc Natl Acad Sci U S A (1998) 1.47
A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom). J Clin Endocrinol Metab (1994) 1.47
Premature ovarian failure in androgen receptor-deficient mice. Proc Natl Acad Sci U S A (2005) 1.44
Subfertility and defective folliculogenesis in female mice lacking androgen receptor. Proc Natl Acad Sci U S A (2004) 1.39
Retracted The ERK signaling cascade inhibits gonadotropin-stimulated steroidogenesis. J Biol Chem (2001) 1.30
Mutations in the steroidogenic acute regulatory protein (StAR) in six patients with congenital lipoid adrenal hyperplasia. J Clin Endocrinol Metab (2000) 1.29
Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf) (2004) 1.29
Epidermal growth factor receptor signaling is required for normal ovarian steroidogenesis and oocyte maturation. Proc Natl Acad Sci U S A (2005) 1.28
Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17 alpha activity and serum androgens. J Clin Endocrinol Metab (1997) 1.21
Progesterone as a mediator of gonadotrophin action in the corpus luteum: beyond steroidogenesis. Hum Reprod Update (2003) 1.20
Developmental roles of the steroidogenic acute regulatory protein (StAR) as revealed by StAR knockout mice. Mol Endocrinol (2000) 1.19
Alterations in mitogen-activated protein kinase kinase and extracellular regulated kinase signaling in theca cells contribute to excessive androgen production in polycystic ovary syndrome. Mol Endocrinol (2004) 1.18
Targeted disruption of the estrogen receptor-alpha gene in female mice: characterization of ovarian responses and phenotype in the adult. Endocrinology (1999) 1.18
Ovarian granulosa cell lines. Mol Cell Endocrinol (2004) 1.17
Hormonal effects of flutamide in young women with polycystic ovary syndrome. J Clin Endocrinol Metab (1998) 1.14
Androgens promote maturation and signaling in mouse oocytes independent of transcription: a release of inhibition model for mammalian oocyte meiosis. Mol Endocrinol (2003) 1.11
Ovarian morphology in long-term androgen-treated female to male transsexuals. A human model for the study of polycystic ovarian syndrome? Histopathology (1991) 1.10
Comparison of follicle steroidogenesis from normal and polycystic ovaries in women undergoing IVF: relationship between steroid concentrations, follicle size, oocyte quality and fecundability. Hum Reprod (2000) 1.10
Activation of mitogen-activated protein kinases by gonadotropins and cyclic adenosine 5'-monophosphates in porcine granulosa cells. Biol Reprod (1996) 1.09
Selective effects of pioglitazone on insulin and androgen abnormalities in normo- and hyperinsulinaemic obese patients with polycystic ovary syndrome. Hum Reprod (2003) 1.08
ERKs regulate cyclic AMP-induced steroid synthesis through transcription of the steroidogenic acute regulatory (StAR) gene. J Biol Chem (2001) 1.08
Role of androgens in follicle maturation and atresia. Baillieres Clin Obstet Gynaecol (1997) 1.06
Insulin-lowering agents in the management of polycystic ovary syndrome. Endocr Rev (2003) 1.05
The importance of insulin resistance in polycystic ovary syndrome. Fertil Steril (2003) 1.05
Insulin action in the normal and polycystic ovary. Endocrinol Metab Clin North Am (1999) 1.05
Selective modulation of genomic and nongenomic androgen responses by androgen receptor ligands. Mol Endocrinol (2003) 1.04
Intracellular signaling in the gonads. Endocr Rev (1992) 1.03
The steroidogenic acute regulatory protein (StAR): a window into the complexities of intracellular cholesterol trafficking. Recent Prog Horm Res (1999) 1.00
Production of progesterone from de novo-synthesized cholesterol in cumulus cells and its physiological role during meiotic resumption of porcine oocytes. Biol Reprod (2002) 0.96
Preovulatory effects of the progesterone antagonist mifepristone (RU486) in mice. Hum Reprod (1991) 0.95
Reproductive phenotypes in the estrogen receptor-alpha knockout mouse. Ann Endocrinol (Paris) (1999) 0.92
Luteinizing hormone/choriogonadotropin receptor-mediated activation of heterotrimeric guanine nucleotide binding proteins in ovarian follicular membranes. Endocrinology (1998) 0.91
Role of cytochrome P450c17 in polycystic ovary syndrome. Mol Cell Endocrinol (1998) 0.90
Mechanisms of insulin-like growth factor I augmentation of follicle-stimulating hormone-induced porcine steroidogenic acute regulatory protein gene promoter activity in granulosa cells. Endocrinology (1999) 0.88
Reproductive functions of the progesterone receptor. J Soc Gynecol Investig (2000) 0.86
Mechanisms of epidermal growth factor signaling: regulation of steroid biosynthesis and the steroidogenic acute regulatory protein in mouse Leydig tumor cells. Biol Reprod (2002) 0.86
Specific modulation of nongenomic androgen signaling in the ovary. Steroids (2005) 0.86
Multiple signal transduction pathways regulate ovarian steroidogenesis. Rev Endocr Metab Disord (2002) 0.85
Estrogen is not directly required for oocyte developmental competence. Biol Reprod (2003) 0.85
A role of insulin-like growth factor I in luteinizing hormone receptor expression in granulosa cells. Endocrinology (1999) 0.84
Human ovarian granulosa cells and follicular fluid indices: the relationship to oocyte maturity and fertilization in vitro. Hum Reprod (1998) 0.84
Concerted regulation of steroidogenic acute regulatory gene expression by luteinizing hormone and insulin (or insulin-like growth factor I) in primary cultures of porcine granulosa-luteal cells. Endocrinology (2000) 0.84
Oocytic meiosis in cultured rat follicles during inhibition of steroidogenesis. Acta Endocrinol (Copenh) (1976) 0.84
Antiandrogen treatment of polycystic ovary syndrome. Endocrinol Metab Clin North Am (1999) 0.83
Effect of insulin-like growth factor-I during preantral follicular culture on steroidogenesis, in vitro oocyte maturation, and embryo development in mice. Biol Reprod (2004) 0.83
Effect of intraovarian factors on porcine follicular cells: cumulus expansion, granulosa and cumulus cell progesterone production. Anim Reprod Sci (2001) 0.83
Regulation of luteinizing hormone receptor messenger ribonucleic acid levels by gonadotropins, growth factors, and gonadotropin-releasing hormone in cultured rat granulosa cells. Endocrinology (1991) 0.83
Treatment of PCOS with metformin and other insulin-sensitizing agents. Curr Diab Rep (2004) 0.82
Regulation of the differentiated functions of Leydig tumor cells by epidermal growth factor. Ann N Y Acad Sci (1989) 0.82
Src tyrosine kinase regulates CYP17 expression and androstenedione secretion in theca-enriched mouse ovarian cells. Endocrine (2004) 0.81
Congenital adrenal hyperplasia: transition from chil dhood to adulthood. J Endocrinol Invest (2001) 0.80
Androgen/antiandrogen modulation of cyclic AMP-induced steroidogenesis during granulosa cell differentiation in tissue culture. Mol Cell Endocrinol (1983) 0.79
Hyperandrogenemia is necessary but not sufficient for polycystic ovary syndrome. Fertil Steril (2003) 0.78
Total estradiol, free estradiol, sex hormone-binding globulin, and the fraction of estradiol bound to sex hormone-binding globulin in human follicular fluid. J Clin Endocrinol Metab (1986) 0.78
What are the key features of importance in polycystic ovary syndrome? Fertil Steril (2003) 0.78
Serum and follicular fluid sex hormone-binding globulin in stimulated and unstimulated cycles. J Assist Reprod Genet (1995) 0.76
Binding of steroids by proteins in follicular fluid of the human ovary. J Clin Endocrinol Metab (1981) 0.76
Granulosa cell-specific androgen receptors are critical regulators of ovarian development and function. Mol Endocrinol (2010) 1.57
Epidermal growth factor receptor signaling is required for normal ovarian steroidogenesis and oocyte maturation. Proc Natl Acad Sci U S A (2005) 1.28
Paxillin regulates androgen- and epidermal growth factor-induced MAPK signaling and cell proliferation in prostate cancer cells. J Biol Chem (2010) 1.24
Androgens regulate ovarian follicular development by increasing follicle stimulating hormone receptor and microRNA-125b expression. Proc Natl Acad Sci U S A (2014) 1.22
Integration of rapid signaling events with steroid hormone receptor action in breast and prostate cancer. Annu Rev Physiol (2007) 1.17
Androgens promote maturation and signaling in mouse oocytes independent of transcription: a release of inhibition model for mammalian oocyte meiosis. Mol Endocrinol (2003) 1.11
Paxillin mediates extranuclear and intranuclear signaling in prostate cancer proliferation. J Clin Invest (2012) 1.09
Cross-talk between G protein-coupled and epidermal growth factor receptors regulates gonadotropin-mediated steroidogenesis in Leydig cells. J Biol Chem (2008) 1.07
Selective modulation of genomic and nongenomic androgen responses by androgen receptor ligands. Mol Endocrinol (2003) 1.04
Oocyte maturation: the coming of age of a germ cell. Semin Reprod Med (2005) 1.02
The modulator of nongenomic actions of the estrogen receptor (MNAR) regulates transcription-independent androgen receptor-mediated signaling: evidence that MNAR participates in G protein-regulated meiosis in Xenopus laevis oocytes. Mol Endocrinol (2005) 1.02
Mediastinal paragangliomas: association with mutations in the succinate dehydrogenase genes and aggressive behavior. Endocr Relat Cancer (2008) 1.02
Central role for PELP1 in nonandrogenic activation of the androgen receptor in prostate cancer. Mol Endocrinol (2012) 0.98
Two cases of malignant struma ovarii with metastasis to pelvic bone. Gynecol Obstet Invest (2013) 0.97
The enantiomer of progesterone acts as a molecular neuroprotectant after traumatic brain injury. Neuropharmacology (2006) 0.95
Uterine-specific loss of Tsc2 leads to myometrial tumors in both the uterus and lungs. Mol Endocrinol (2013) 0.90
Testosterone and progesterone rapidly attenuate plasma membrane Gbetagamma-mediated signaling in Xenopus laevis oocytes by signaling through classical steroid receptors. Mol Endocrinol (2006) 0.90
Expression of the germ cell-specific transcription factor ALF in Xenopus oocytes compensates for translational inactivation of the somatic factor TFIIA. J Biol Chem (2003) 0.89
Fasting-induced hepatic production of DHEA is regulated by PGC-1alpha, ERRalpha, and HNF4alpha. Mol Endocrinol (2009) 0.88
GPCR/EGFR cross talk is conserved in gonadal and adrenal steroidogenesis but is uniquely regulated by matrix metalloproteinases 2 and 9 in the ovary. Mol Endocrinol (2011) 0.87
Specific modulation of nongenomic androgen signaling in the ovary. Steroids (2005) 0.86
Paxillin regulates steroid-triggered meiotic resumption in oocytes by enhancing an all-or-none positive feedback kinase loop. J Biol Chem (2006) 0.85
Understanding extranuclear (nongenomic) androgen signaling: what a frog oocyte can tell us about human biology. Steroids (2011) 0.85
A local paracrine and endocrine network involving TGFβ, Cox-2, ROS, and estrogen receptor β influences reactive stromal cell regulation of prostate cancer cell motility. Mol Endocrinol (2012) 0.85
Xenopus laevis ovarian CYP17 is a highly potent enzyme expressed exclusively in oocytes. Evidence that oocytes play a critical role in Xenopus ovarian androgen production. J Biol Chem (2003) 0.83
The Xenopus laevis isoform of G protein-coupled receptor 3 (GPR3) is a constitutively active cell surface receptor that participates in maintaining meiotic arrest in X. laevis oocytes. Mol Endocrinol (2008) 0.83
G beta gamma signaling reduces intracellular cAMP to promote meiotic progression in mouse oocytes. Steroids (2006) 0.82
The physiology of the Xenopus laevis ovary. Methods Mol Biol (2006) 0.82
GLP-1: a novel zinc finger protein required in somatic cells of the gonad for germ cell development. Dev Biol (2006) 0.80
Nongenomic steroid-triggered oocyte maturation: of mice and frogs. Steroids (2008) 0.80
Just when you thought it was safe to go into the membrane: the growing complexities of extra-nuclear progesterone signaling. Breast Cancer Res (2010) 0.77
GATA-like protein-1 (GLP-1) is required for normal germ cell development during embryonic oogenesis. Reproduction (2010) 0.77
Membrane receptor cross talk in steroidogenesis: recent insights and clinical implications. Steroids (2013) 0.76
Xenopus laevis CYP17 regulates androgen biosynthesis independent of the cofactor cytochrome b5. J Biol Chem (2005) 0.75
Statement of principle. J Clin Endocrinol Metab (2014) 0.75
New member of the trefoil factor family of proteins is an alpha-macroglobulin protease inhibitor. Biochim Biophys Acta (2002) 0.75
Statement of principle. Horm Cancer (2015) 0.75
Meeting review: Extra-nuclear steroid receptors-Integration with multiple signaling pathways. Steroids (2008) 0.75
The physiology of integrated nuclear and extranuclear steroid signaling: introductory comments. Steroids (2011) 0.75
Editorial: Final Musings on the Impact of Molecular Endocrinology. Mol Endocrinol (2016) 0.75
Recent insights on circulating catecholamines in hypertension. Curr Hypertens Rep (2014) 0.75
Statement of principle. Endocr Rev (2014) 0.75